Announcements - OBI Pharma 台灣浩鼎

2019.Mar.08

Board of Directors approved the Company’s 2018 individual and consolidated financial statements

2019.Mar.08

Announcement of the resolution of the treasury shares and the establishment of the base date for capital reduction by board of directors

2019.Feb.20

Clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study by Ministry of Health of Ukraine

2019.Feb.13

Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica

2019.Jan.03

OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare Conference

2018.Dec.28

Company Chairman Mr. Michael N. Chang not guilty for the prosecution by Taiwan Shilin District Court

2018.Dec.19

OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta

2018.Dec.03

OBI Pharma Inc. to attend the Citi's 2018 Global Healthcare Conference

2018.Nov.30

Announcement of the resolution of the board of directors of the company to issue common shares through rights offering

2018.Nov.23

OBI Pharma Inc. to attend the 2018 Asia Pacific Healthcare Forum, hosted by Goldman Sachs

News

Latest News

Events

Latest events